NCT00699725已完成不适用
Compliance of Gastroprotection Treatment in the Prevention of Gastrointestinal Risk in Non-Steroidal Anti-inflammatory Drug (NSAID) Using Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Adherence to gastroprotection treatment
研究概览
简要总结
Prospective multicentric study to evaluate the compliance of gastroprotective treatment in NSAID patients at risk of GI complications. Secondary objectives: To identify the factors associated to treatment compliance (both NSAID and PPI), to evaluate the relationship between compliance and NSAID-associated GI events
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed informed consent
- •Patients consulting to the specialized care clinics who have been prescribed NSAID and gastroprotection for at least 15 days following standard clinical practice.
排除标准
- •Any gastroprotective treatment prescribed for other condition than NSAID-related gastrointestinal event prevention
结局指标
主要结局
Adherence to gastroprotection treatment
时间窗: End of follow-up (3-5 weeks)
次要结局
- Identify factors associated with treatment compliance(End of follow-up)
- Evaluate the relationship among GI events and treatment compliance(End of follow-up)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in FranceHealthyNCT01211652AstraZeneca8,186
撤回
不适用
Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) UlcerGastrointestinal HemorrhageUlcerNCT01215058AstraZeneca
撤回
不适用
Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in FranceSelf-administered Questionnaire to PatientsNCT01238809AstraZeneca7,300
暂停
不适用
Observational Study on Monitoring NSAID-Induced Gastropathy in Patients Using Magnetically-Controlled Capsule GastroscopyNSAID-Associated GastropathyNCT06027060Shanghai Jiao Tong University School of Medicine180
已完成
不适用
Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mgAspirinDrug SafetyEffects, LongtermNCT01669824Bayer4,235